Algeta ASA was a Norwegian biopharmaceutical company focused on developing targeted radiopharmaceutical cancer treatments. Its leading product, Xofigo (radium-223 dichloride)…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Algeta ASA →Already a subscriber? Sign in
Xcout Intel tracks Algeta ASA continuously — this profile deepens as new filings, funding, people and hiring data arrive.